Randomized controlled trial of monthly versus biweekly endoscopic variceal ligation for the prevention of esophageal variceal rebleeding

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1229-1236

  Wang, Huay Min ^a   Lo, Gin Ho ^b   Chen, Wen Chi ^a   Chan, Hoi Hung ^a   Tsai, Wei Lun ^a   Yu, Hsien Chung ^a   Tsay, Feng Woei ^a   Hsu, Ping I ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

Author keywords

Endoscopic variceal ligation; Post EVL ulcer; Variceal bleeding

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE BUTYL BROMIDE; SOMATOSAN; TERLIPRESSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CHEST TIGHTNESS; CHILD PUGH SCORE; CONTROLLED STUDY; DYSPHAGIA; ENDOSCOPIC SURGERY; ENDOSCOPIC VARICEAL LIGATION; ESCHERICHIA COLI INFECTION; ESOPHAGEAL VARICEAL REBLEEDING; ESOPHAGUS HEMORRHAGE; ESOPHAGUS ULCER; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; ODYNOPHAGIA; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSTERNAL PAIN; RISK FACTOR; STOMACH DISEASE; STOMACH VARICES; SURVIVAL RATE; ULCER HEALING; UPPER GASTROINTESTINAL BLEEDING; UREMIA; ACUTE DISEASE; COMPLICATION; EMERGENCY; HEMORRHAGE; LIGATION; MIDDLE AGED; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; EMERGENCIES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; LIGATION; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900552555     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12538     Document Type: Article

References (22)

1. Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet 2003; 361: 952-954.
2. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann. Intern. Med. 1995; 123: 280-287.
3. Garcia-Tsao G, Sanyal AJ, Grace ND etal. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am. J. Gastroenterol. 2007; 102: 2086-2102.
4. Garcia-Tsao G. Current management of the adverse events of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120: 726-748.
5. Lo GH, Chen WC, Chan HH etal. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J. Gastroenterol. Hepatol. 2009; 24: 982-987.
6. Lo GH, Chen WC, Chen MH etal. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 728-734.
7. Lo GH, Lai KH. The optimal interval of endoscopic variceal ligation. Hepatology 2008; 47: 1429.
8. Yoshida H, Mamada Y, Taniai N etal. A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of esophageal varices. Am. J. Gastroenterol. 2005; 100: 2005-2009.
9. Harewood GC, Baron TH, Song LM. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding. J. Gastroenterol. Hepatol. 2006; 21: 237-241.
10. Pugh RN, Murray-Lyon IM, Dawson JL etal. Transection of esophagus for bleeding esophageal varices. Br. J. Surg. 1973; 60: 646-649.
11. Beppu K, Inokuchi K, Koyanagi N etal. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 1981; 27: 213-218.
12. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2005; 43: 167-176.
13. Patch D, Sabin CA, Goulis J etal. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 1013-1019.
14. Sarin SK, Sachdev G, Nanda R etal. Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut 1986; 27: 710-713.
15. Westaby D, Melia WM, MacDougall BR etal. Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules. Gut 1984; 25: 129-132.
16. Lo GH. The role of endoscopy in secondary prophylaxis of esophageal varices. Clin. Liver Dis. 2010; 14: 307-323.
17. de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin. Liver Dis. 1999; 19: 439-455.
18. Poza Cordon J, Froilan Torres C, Burgos García A etal. Endoscopic management of esophageal varices. World J. Gastrointest. Endosc. 2012; 4: 312-322.
19. Baron TH, Wong Kee Song LM. Endoscopic variceal band ligation. Am. J. Gastroenterol. 2009; 104: 1083-1085.
20. Lo GH, Lai KH, Cheng JS etal. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology 1998; 28: 391-395.
21. Vanbiervliet G, Giudicelli-Bornard S, Piche T etal. Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment. Pharmacol. Ther. 2010; 32: 225-232.
22. Hou MC, Lin HC, Lee FY etal. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J. Hepatol. 2000; 32: 202-208.